The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review
Author:
Affiliation:
1. Oncology Unit, Sotiria General Hospital, Athens School of Medicine, Athens, Greece
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07357907.2016.1206117
Reference84 articles.
1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
2. Cancer statistics, 2015
3. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
4. New insights into ovarian cancer pathology
5. Diverse molecular pathways in ovarian cancer and their clinical significance
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review);International Journal of Oncology;2022-12-27
2. Current progress and open challenges for applying tyrosine kinase inhibitors in osteosarcoma;Cell Death Discovery;2022-12-12
3. Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome;International Journal of Oncology;2022-09-08
4. Macrophage migration inhibitory factor takes part in the lumbar ligamentum flavum hypertrophy;Molecular Medicine Reports;2022-07-27
5. Molecular methods for increasing the effectiveness of ovarian cancer treatment: a systematic review;Future Oncology;2022-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3